Navigation Links
AlphaRx Reports Positive Preclinical Data on GAI-122 Against Liver Disease
Date:7/8/2009

veloping proven therapies by reformulating FDA approved and marketed drugs which through the application of its proprietary site-specific nano drug delivery technology, offers improved medical benefits and a potential for significant commercial product development.

About Gaia BioPharma

Gaia BioPharma Limited, a privately held, early stage biopharmaceutical company focused on hospital-based injectable therapeutics. Gaia BioPharma seeks to address key unmet therapeutic needs by taking established compounds and changing their administration routes to create patent-protected, value-added products.

FORWARD LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.


'/>"/>
SOURCE AlphaRx Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. AlphaRx and Gaia BioPharma Report Positive Efficacy Results in a Pre-Clinical Trial of GAI-122 Injectable Nano-emulsion for Post-operative Delirium
2. AlphaRx Shareholder Update
3. AlphaRx and Gaia BioPharma Provide GAI-122 Development Update
4. AlphaRx Signs Cooperative Research and Development Agreement with US Army
5. AlphaRx Provides Corporate and Development Update
6. AlphaRxs Indaflex(TM) Continues its Clinical Development
7. AlphaRx CEO Accumulates More Company Shares
8. AlphaRx Officers and Directors To Exercise Options, Warrants and Retain Shares
9. AlphaRx Announces Debt Conversion
10. AlphaRx To Present at 47th Annual ICAAC
11. Recent News Reports of Sweetener Reformulations Raise Questions About Motivations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 2014 Top10BestSEOHosting.com has recently compared ... FatCow, Hostgator and Bluehost are the best hosting ... has been working in the hosting industry for ... connected to multiple GB connections to ensure that ... to customers’ websites. The great thing is that ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group recently announced ... extremely large, and Millennium Treatment Group is working to close ... they need. , According to the National Survey on ... million Americans could have benefited from treatment for drug and/or ... help. This means that there is a large treatment gap ...
(Date:8/28/2014)... Steven Reinberg HealthDay ... Too much salt in the diet may worsen symptoms of ... "Many environmental factors affect MS, such as vitamin D, smoking ... salt intake may be another environmental factor affecting MS patients," ... Institute for Neurological Research in Buenos Aires. Multiple sclerosis ...
(Date:8/28/2014)... August 28, 2014 The Governor of ... Summit at a press conference; this event is ... the Ministry of Economy through the National Microenterprise Financing ... September 2nd to the 5th at the Convention Center ... “It is a great responsibility for Yucatan to host ...
(Date:8/28/2014)... CA (PRWEB) August 28, 2014 Gurnick ... the MRI Technology program is re-accredited for the 5 ... Magnetic Resonance Imaging Technologists (ARMRIT). , “We are ... are constantly improving our program to make sure we ... a lot of interest in MRI field nowadays and ...
Breaking Medicine News(10 mins):Health News:Best Suppliers of Affordable Hosting Products Introduced by Top10BestSEOHosting.com 2Health News:Millennium Treatment Group Works to Close Treatment Gap 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 2Health News:Governor of the State of Yucatan presents the 17th Microcredit Summit 3Health News:Gurnick Academy’s MRI Program Is Re-Accredited by ARMRIT for the 5 Years 2
... anti-inflammatory activity of novel CCR2 antagonist in ... patients at high-risk for atherosclerosis -, ... MLNM ) today announced that MLN1202, a novel,humanized monoclonal ... levels in a placebo-controlled, Phase II trial of,patients at ...
... two habits work together to maintain addiction, study suggests ... bar patrons know all too well, drinking and smoking ... why that might be so. , It,s well known ... lower if someone continues smoking," noted lead researcher Thomas ...
... Nov. 6 MicroActive Corporation, a,subsidiary of Barrier ... acquired by Linden LLC and The Edgewater Funds. ... Microflex Corporation and,FoodHandler, Inc. BSSI, headquartered in Reno, ... barrier products to the foodservice, emergency medical,dental, laboratory, ...
... of Human Infection; Congress Needs to Compel ... new study published in,Veterinary Microbiology found methicillin-resistant Staphylococcus ... farmers, pointing to animal,agriculture as a source of ... (Khanna et al. 2007) is the first to,show ...
... initiatives encourage smokers to say ,I Quit, at The ... Tech Museum ... going on at the BODY WORLDS exhibit. Lung Cancer Awareness,Month activities ... Kickers Quit Smoking Class and BODY WORLDS, I Quit smoking,cessation program. ...
... Winner from More Than 1,000 Nominations for ,Thank,Your Vet for a Healthy ... ... Nov. 6 Veterinarians play a critical role in,keeping our pets healthy, ... Ph.D., going above and beyond,when it comes to caring for animals is ...
Cached Medicine News:Health News:Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders 2Health News:Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders 3Health News:Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders 4Health News:Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders 5Health News:Nicotine Plus Alcohol May Be Tough to Beat 2Health News:Nicotine Plus Alcohol May Be Tough to Beat 3Health News:MicroActive Corporation Acquired by Linden and Edgewater 2Health News:New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 2Health News:New Study Reveals MRSA Bacteria Common Among Pigs and Farm Workers 3Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 2Health News:BODY WORLDS 2 & Breathe California Pair Up for Some 'Ash Kicking' 3Health News:University of Missouri Veterinarian Wins America's Best Vet Honor; Four Regional Winners Also Named 2Health News:University of Missouri Veterinarian Wins America's Best Vet Honor; Four Regional Winners Also Named 3Health News:University of Missouri Veterinarian Wins America's Best Vet Honor; Four Regional Winners Also Named 4
(Date:8/28/2014)... 28, 2014 /PRNewswire-iReach/ -- Gateway Analytical announced today ... th Annual Global Pharma Manufacturing Summit in ... th . The Global Pharma Manufacturing Summit offers ... molecule and biologic pharmaceutical manufacturing. The conference is ... manufacturers face, such as the increasing pressure to ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Markets to 2020 - Novel Therapeutic ... Newly Diagnosed and Recurrent GBM ... Glioblastoma Multiforme Therapeutics in ...
(Date:8/28/2014)... 2014  Robotic surgery is creating buzz among ... the promise of improved outcomes and the potential ... surgical robots and market pressures to use this ... their robotic surgery training programs and ensure proper ... ECRI Institute ( www.ecri.org ), a nonprofit ...
Breaking Medicine Technology:Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 2Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 3Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 4Surgical Robot Risk and Safety: ECRI Institute and Hartford Hospital Launch New Education Series 5
... today announced that the U.S. Patent and Trademark ... key patent application, "Mechanical Method and Apparatus for ... covering the method of the INSORB Skin Closure ... now sold over 500,000 INSORB® Absorbable Skin Staplers ...
... Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available... -- DALLAS, September 28, 2010 ... ... lpUnit=,PRN,; --> ... { var s = ,; var first_result; // Results are keyed by longUrl, so we need to ...
Cached Medicine Technology:Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent 2Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent 3Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 2Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 3Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 4Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 5Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 6Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 7Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 8Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 9
... Healing Shoe offers the most advanced design ... allowing patients to maintain their mobility. Thanks ... even larger portion of the forefoot is ... heads and toes to heal faster. OrthoWedge ...
The choice for inclement weather. This boot provides both closed toe and heel with a moisture resistant vinyl upper....
Ideal for use with thinner casting materials such as polyester or fiberglass. Conforms to any casting material....
This lightweight cast boot features a sturdy canvas upper. The three layer EVA rocker outsole provides excellent shock absorption....
Medicine Products: